Wilforlide A
CAS: 84104-71-2
Ref. 3D-FW65700
| 5mg | 165.00 € | ||
| 10mg | 238.00 € | ||
| 25mg | 447.00 € | ||
| 50mg | 647.00 € | ||
| 100mg | 1,044.00 € |
Product Information
- (-)-Abruslactone A
- 4,2-(Epoxymethano)picene, olean-12-en-29-oic acid deriv.
- Olean-12-En-29-One, 22,29-Epoxy-3-Hydroxy-, (3Beta,22Alpha)-
- Olean-12-en-29-oic acid, 3,22-dihydroxy-, γ-lactone, (3β,20α,22α)-
- Regelide
Wilforlide A is a novel anticancer drug that inhibits the growth of cancer cells by inhibiting amino transferase and blocking the synthesis of DNA. Wilforlide A has synergistic effects when used in combination with tripterygium wilfordii, a Chinese herb, and moronic acid, an extract from Tripterygium wilfordii. Wilforlide A also has anti-inflammatory properties and can be used to treat autoimmune diseases. The efficacy of Wilforlide A was evaluated using surface methodology on human skin squamous carcinoma samples. It was found that Wilforlide A had no cytotoxicity when applied to these cells. In addition, it inhibited tumor growth in mice inoculated with human squamous carcinoma cells. These findings show that Wilforlide A is a potential candidate for treating squamous carcinoma patients.
Chemical properties
Technical inquiry about: 3D-FW65700 Wilforlide A
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
